Metropolitan Life Insurance CO Cabaletta Bio, Inc. Transaction History
Metropolitan Life Insurance CO
- $252 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.4MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$5.23 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$4.48 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$3.15 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$3.04 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $31.9M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...